Affordable Access

Ranolazine for Congenital Long-QT Syndrome Type III: Experimental and Long-Term Clinical Data.

Authors
  • Chorin, Ehud1
  • Hu, Dan1
  • Antzelevitch, Charles1
  • Hochstadt, Aviram1
  • Belardinelli, Luiz1
  • Zeltser, David1
  • Barajas-Martinez, Hector1
  • Rozovski, Uri1
  • Rosso, Raphael1
  • Adler, Arnon1
  • Benhorin, Jesaia1
  • Viskin, Sami2
  • 1 From the Tel Aviv Sourasky Medical Center and Sackler School of Medicine, Tel Aviv University, Israel (E.C., A.H., D.Z., U.R., R.R., A.A., J.B., S.V.); Masonic Medical Research Laboratory, Utica, NY (D.H., C.A., H.B.-M.); Cardiovascular Research Program, Lankenau Institute for Medical Research, Wynnewood, PA (C.A.); and Gilead Sciences, Inc, Foster City, CA (L.B.).
  • 2 From the Tel Aviv Sourasky Medical Center and Sackler School of Medicine, Tel Aviv University, Israel (E.C., A.H., D.Z., U.R., R.R., A.A., J.B., S.V.); Masonic Medical Research Laboratory, Utica, NY (D.H., C.A., H.B.-M.); Cardiovascular Research Program, Lankenau Institute for Medical Research, Wynnewood, PA (C.A.); and Gilead Sciences, Inc, Foster City, CA (L.B.). [email protected]
Type
Published Article
Journal
Circulation Arrhythmia and Electrophysiology
Publisher
Ovid Technologies Wolters Kluwer -American Heart Association
Publication Date
October 2016
Volume
9
Issue
10
Identifiers
PMID: 27733495
Source
Medline
Keywords
License
Unknown

Abstract

URL: https://clinicaltrials.gov; Unique identifier: NCT01728025.

Report this publication

Statistics

Seen <100 times